A team including Regenstrief Institute and Indiana University research scientists has published an in-depth case study on the Indiana Network for Patient Care (INPC), revealing how this mature health ...

Multidrug-resistant bacteria kill five million people each year, with newly resistant germs emerging faster than scientists ...

Multidrug-resistant organisms (MDROs) are a major challenge in everyday medical practice, as they often cannot be treated with antibiotics. According to the Robert Koch Institute, there are ...

Hospitalised children with severe acute malnutrition show high rates of colonisation with drug-resistant bacteria, raising ...

Multidrug-resistant organisms (MDROs) are a major challenge in everyday medical practice, as they often cannot be treated with antibiotics.

The global tuberculin skin test market size was US$ 2,236.1 million in 2021. The global tuberculin skin test market size is forecast to reach US$ 3,380.7 million by 2030, growing at a compound annual ...

BARDA has given $24 million to Locus Bio to support a mid-stage trial of bacteriophage therapy LBP-EC01 for resistant E coli infections.

Although drugs like Doxorubicin (DOX) are commonly used, their effectiveness is often limited by toxicity, poor targeting, and the development of multi-drug resistance. DNA nanostructures, due to ...

Recent studies have shed light on the virulence factors of pathogenic bacteria, fungi, oomycota and microalgae, and their intrinsic or acquired resistance mechanisms ... your team of co-editors, ...